Lee JC - Search Results

1

Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.

Rudick RA, Lee JC, Simon J, Fisher E. Rudick RA, et al. Among authors: lee jc. Ann Neurol. 2006 Aug;60(2):236-42. doi: 10.1002/ana.20883. Ann Neurol. 2006. PMID: 16786526

2

Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression.

Moldovan IR, Rudick RA, Cotleur AC, Born SE, Lee JC, Karafa MT, Pelfrey CM. Moldovan IR, et al. Among authors: lee jc. J Neuroimmunol. 2003 Aug;141(1-2):132-40. doi: 10.1016/s0165-5728(03)00221-2. J Neuroimmunol. 2003. PMID: 12965264

3

Defining interferon beta response status in multiple sclerosis patients.

Rudick RA, Lee JC, Simon J, Ransohoff RM, Fisher E. Rudick RA, et al. Among authors: lee jc. Ann Neurol. 2004 Oct;56(4):548-55. doi: 10.1002/ana.20224. Ann Neurol. 2004. PMID: 15389896 Clinical Trial.

4

Association of fatigue and brain atrophy in multiple sclerosis.

Marrie RA, Fisher E, Miller DM, Lee JC, Rudick RA. Marrie RA, et al. Among authors: lee jc. J Neurol Sci. 2005 Feb 15;228(2):161-6. doi: 10.1016/j.jns.2004.11.046. Epub 2004 Dec 21. J Neurol Sci. 2005. PMID: 15694198

5

Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications.

Fox RJ, Fisher E, Tkach J, Lee JC, Cohen JA, Rudick RA. Fox RJ, et al. Among authors: lee jc. Mult Scler. 2005 Apr;11(2):140-5. doi: 10.1191/1352458505ms1142oa. Mult Scler. 2005. PMID: 15794385 Clinical Trial.

6

Gray matter atrophy in multiple sclerosis: a longitudinal study.

Fisher E, Lee JC, Nakamura K, Rudick RA. Fisher E, et al. Among authors: lee jc. Ann Neurol. 2008 Sep;64(3):255-65. doi: 10.1002/ana.21436. Ann Neurol. 2008. PMID: 18661561

7

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.

Rudick RA, Lee JC, Nakamura K, Fisher E. Rudick RA, et al. Among authors: lee jc. J Neurol Sci. 2009 Jul 15;282(1-2):106-11. doi: 10.1016/j.jns.2008.11.018. Epub 2008 Dec 19. J Neurol Sci. 2009. PMID: 19100997 Free PMC article.

8

Disability progression in a clinical trial of relapsing-remitting multiple sclerosis: eight-year follow-up.

Rudick RA, Lee JC, Cutter GR, Miller DM, Bourdette D, Weinstock-Guttman B, Hyde R, Zhang H, You X. Rudick RA, et al. Among authors: lee jc. Arch Neurol. 2010 Nov;67(11):1329-35. doi: 10.1001/archneurol.2010.150. Epub 2010 Jul 12. Arch Neurol. 2010. PMID: 20625068 Clinical Trial.

9

Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosis.

Rudick RA, Rani MR, Xu Y, Lee JC, Na J, Shrock J, Josyula A, Fisher E, Ransohoff RM. Rudick RA, et al. Among authors: lee jc. PLoS One. 2011;6(5):e19262. doi: 10.1371/journal.pone.0019262. Epub 2011 May 13. PLoS One. 2011. PMID: 21602934 Free PMC article. Clinical Trial.

10

Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.

Moll NM, Rietsch AM, Thomas S, Ransohoff AJ, Lee JC, Fox R, Chang A, Ransohoff RM, Fisher E. Moll NM, et al. Among authors: lee jc. Ann Neurol. 2011 Nov;70(5):764-73. doi: 10.1002/ana.22521. Ann Neurol. 2011. PMID: 22162059 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,968 results

Search Page

Filters